Not applicableUnknownNCT01898325What this trial is testingAssessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using FibroscanWho this might be right forFibrosis Rambam Health Care Campus 40
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Early research (Phase 1)Study completedNCT00019838What this trial is testingUCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Not applicableEnded earlyNCT00255684What this trial is testingFludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more University of Rochester 16
Large-scale testing (Phase 3)UnknownNCT00003924What this trial is testingInterferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaWho this might be right forLymphoma Lymphoma Study Association 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562870What this trial is testingEvaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated MyelofibrosisWho this might be right forMyelofibrosis Karyopharm Therapeutics Inc 112
Not applicableUnknownNCT02077283What this trial is testingUrinary Metabonomics of Two Major Patterns of NAFLDWho this might be right forNon-alcoholic Fatty Liver Disease ShuGuang Hospital 114
Early research (Phase 1)Study completedNCT00589381What this trial is testingFenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 30
Not applicableStudy completedNCT05044663What this trial is testingLiver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease.Who this might be right forChronic Liver Disease Institute of Liver and Biliary Sciences, India 325
Not applicableStudy completedNCT00898872What this trial is testingSWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical TrialWho this might be right forLymphoma SWOG Cancer Research Network 32
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00867529What this trial is testingRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT00007839What this trial is testingBeta Alethine in Treating Patients With Low-Grade LymphomaWho this might be right forLymphoma LifeTime Pharmaceuticals
Early research (Phase 1)Study completedNCT00019656What this trial is testingPerifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+2 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00005967What this trial is testingTipifarnib in Treating Patients With Advanced Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Cancer Institute (NCI) 36
Not applicableStudy completedNCT04890899What this trial is testingSplenic Surgery for Hydatid Spleen in Single Institutional ExperienceWho this might be right forSpleen; Cyst, Hydatid (Manifestation) Jabir Ibn Hayyan Medical University 10
Early research (Phase 1)Ended earlyNCT01643603What this trial is testingDasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more Barbara Ann Karmanos Cancer Institute 5